The Texas Tech University School of Law Digital Repository

Supreme Court’s FDA Decisions Highlights Little Understood Issue of Preemption

Show simple item record

dc.contributor.author Bard, Jennifer S.
dc.date.accessioned 2010-03-31T18:29:39Z
dc.date.available 2010-03-31T18:29:39Z
dc.date.issued 2008
dc.identifier.citation ASBH Exchange (Am. Soc’y for Bioethics and Humanities, Glenview, Ill.), Spring 2008, at 6-7 en_US
dc.identifier.uri http://hdl.handle.net/10601/294
dc.description.abstract Professor Bard analyzes the Supreme Court’s decision in Riegel v. Medtronic, 552 U.S. 312 (2008), as a way to highlight how the Supreme Court approaches the issue of preemption.
dc.language.iso en_US en_US
dc.relation.uri http://www.asbh.org/publications/pdfs/spg.pdf
dc.title Supreme Court’s FDA Decisions Highlights Little Understood Issue of Preemption en_US
dc.type Article en_US


Files in this item

Files Size Format View
bard sup.ct..pdf 1.066Mb PDF View/Open

This item appears in the following Collection(s)

Show simple item record

Search ScHOLAR

Browse

My Account